SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s12094-018-02002-w/fulltext.html
Reference47 articles.
1. Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Roja D, et al. Cancer incidence in Spain, 2015. Clin Trasl. Oncol. 2017;19:799–825.
2. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis. 2001;33:139–44.
3. - Amin, MB, Greene F, Edge S, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual (ed. 8th edition). New York: Springer; 2016.
4. Chibaudel B, Bonnetain F, Tournigand C, Bengrine-Lefevre L, Teixeira L, Artru P, et al. Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR Study. Oncologist. 2011;16:1228–38.
5. Arnold D, Lueza B, Douillard J-Y, Peeters M, Lenz HJ, Venook A, et al. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol. 2017;28(8):1713–29.
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases;Cochrane Database of Systematic Reviews;2024-08-09
2. Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: A Delphi consensus statement;European Journal of Surgical Oncology;2024-06
3. Antitumorigenic effect of combination treatment with BRAF inhibitor and cisplatin in colorectal cancer in vitro and in vivo;2024-03-21
4. Preoperative 18F-FDG PET/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up;Cancers;2024-01-04
5. CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis Patients;Journal of Cancer;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3